Rikke Løvendahl Eefsen

1.1k total citations
32 papers, 624 citations indexed

About

Rikke Løvendahl Eefsen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Rikke Løvendahl Eefsen has authored 32 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Rikke Løvendahl Eefsen's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Rikke Løvendahl Eefsen is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Rikke Løvendahl Eefsen collaborates with scholars based in Denmark, Belgium and Sweden. Rikke Løvendahl Eefsen's co-authors include Martin Illemann, Gunilla Høyer‐Hansen, Ben Vainer, Gert G. Van den Eynden, Pnina Brodt, Peter Vermeulen, Ali W. Majeed, Nigel C. Bird, Andrew R. Reynolds and K. Nielsen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rikke Løvendahl Eefsen

29 papers receiving 620 citations

Peers

Countries citing papers authored by Rikke Løvendahl Eefsen

Since Specialization

Citations

This map shows the geographic impact of Rikke Løvendahl Eefsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikke Løvendahl Eefsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikke Løvendahl Eefsen more than expected).

Fields of papers citing papers by Rikke Løvendahl Eefsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikke Løvendahl Eefsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikke Løvendahl Eefsen. The network helps show where Rikke Løvendahl Eefsen may publish in the future.

Co-authorship network of co-authors of Rikke Løvendahl Eefsen

This figure shows the co-authorship network connecting the top 25 collaborators of Rikke Løvendahl Eefsen. A scholar is included among the top collaborators of Rikke Løvendahl Eefsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikke Løvendahl Eefsen. Rikke Løvendahl Eefsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Olfred Hansen, Tine Bjørn Nielsen, (unknown), Mirjana Josipović, Laurids Østergaard Poulsen, (unknown), (unknown), (unknown), Marie Johansen, (unknown), (unknown), Rikke Løvendahl Eefsen, Eva Serup‐Hansen, Michael Brun Andersen, Poul Geertsen, Ivan R. Vogelius, C.F. Behrens, Gitte Fredberg Persson	0
2	Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer 2024 ·Clinical Cancer Research ·Eric Van Cutsem, Joëlle Collignon, Rikke Løvendahl Eefsen, Sebastian Ochsenreither, Zanete Zvirbule, (unknown), Dirk Arnold, (unknown), Per Pfeiffer, Jeffrey Yachnin, (unknown), (unknown), Annika Sanfridson, Nedjad Losic, Ignacio Garcia‐Ribas, Dominique Tersago, Ahmad Awada	2
3	19-BI-1808-01, a phase 1/2a clinical trial of BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter with or without pembrolizumab. 2024 ·Journal of Clinical Oncology ·Kristoffer Staal Rohrberg, Zsuzsanna Pápai, Rikke Løvendahl Eefsen, Jeffrey Yachnin, Ana Carneiro, Sean H. Lim, Harriet S. Walter, István Láng, Edvard Abel, Kirstie L.S. Cleary, Mark S. Cragg, Robert Oldham, (unknown), (unknown), Ingrid Karlsson, Johan Wallin, Michael Chisamore, Ingrid Teige, Björn Frendéus, Andrés McAllister	1
4	Targeted Treatment of Metastatic Triple‐Negative Breast Cancer: A Systematic Review 2024 ·The Breast Journal ·(unknown), Rikke Løvendahl Eefsen, Dorte Nielsen, Iben Kümler	3
5	Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma 2024 ·Immuno-Oncology Technology ·(unknown), (unknown), (unknown), (unknown), Eva Ellebæk, Marco Donia, Rikke Løvendahl Eefsen, Christian von Buchwald, Claudia Kistler, João M. Santos, (unknown), (unknown), Marie Christine Wulff Westergaard, Dafne C.A. Quixabeira, (unknown), Riikka Havunen, (unknown), Víctor Cervera-Carrascón, (unknown), Inge Marie Svane	2
6	ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy 2023 ·Cancer Gene Therapy ·(unknown), (unknown), (unknown), Rikke Løvendahl Eefsen, Martin Illemann, (unknown), (unknown), Alexia Lopresti, Reidar Albrechtsen, Claus Storgaard Sørensen, Xiao‐Feng Sun, Marie Kveiborg, Sebastian Gnosa	5
7	Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer 2023 ·International Journal of Cancer ·Rikke Løvendahl Eefsen, Jim S. Larsen, Louise Laurberg Klarskov, (unknown), Estrid Høgdall, Peter Ingeholm, Jakob Lykke, Dorte Nielsen, Per Pfeiffer, Laurids Østergaard Poulsen, Camilla Qvortrup, Jakob Vasehus Schou, Morten Mau‐Sørensen, Kell Østerlind, Benny Vittrup Jensen	9
8	ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial 2023 ·BMC Cancer ·(unknown), Martin Højgaard, Kristoffer Staal Rohrberg, Iben Spanggaard, Britt Elmedal Laursen, Morten Ladekarl, Charlotte Aaquist Haslund, Laurine Bente Schram Harsløf, (unknown), Julie Gehl, Lise Søndergaard, Rikke Løvendahl Eefsen, Karin Holmskov Hansen, Annette Raskov Kodahl, Lars Henrik Jensen, Marianne Ingerslev Holt, (unknown), Christina W. Yde, Lise Barlebo Ahlborn, Ulrik Lassen	11
9	Randomised phase II trial of stereotactic body radiotherapy in combination withcheckpoint inhibitors in metastatic castration-resistantprostate cancer (CheckPRO): a study protocol 2023 ·BMJ Open ·(unknown), Gitte Fredberg Persson, Susann Theile, Dorte Nielsen, Estrid Høgdall, (unknown), Helle Westergren Hendel, Torben Lorentzen, Inge Marie Svane, Henriette Lindberg, Rikke Løvendahl Eefsen	2
10	1685P COLAR: Results from an intervention study investigating IL-6 blockade with tocilizumab for treatment of immune checkpoint inhibitor induced colitis and arthritis 2021 ·Annals of Oncology ·(unknown), Ole Haagen Nielsen, Søren Jacobsen, Lene Riis, Susann Theile, Jacob Tveiten Bjerrum, Peter Vilmann, Julia S. Johansen, Mogens K. Boisen, Rikke Løvendahl Eefsen, Inge Marie Svane, Dorte Nielsen, (unknown)	1
11	538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC) 2021 ·Annals of Oncology ·Ahmad Awada, (unknown), Sebastian Ochsenreither, Rikke Løvendahl Eefsen, Dirk Arnold, Saulius Cicėnas, Jeffrey Yachnin, Per Pfeiffer, Luis Paz‐Ares, Christiane Jungels, Richard Greil, Laurids Østergaard Poulsen, Eric Van Cutsem, (unknown), Lars Thorsson, Joëlle Collignon	1
12	An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine 2019 ·Cancer Chemotherapy and Pharmacology ·Iben Kümler, Rikke Løvendahl Eefsen, Peter G. Sørensen, Susann Theile, Aaron Fullerton, P. Gamborg Nielsen, Benny Vittrup Jensen, Dorte Nielsen	5
13	The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study 2015 ·Clinical Cancer Research ·(unknown), Ib Jarle Christensen, Ben Vainer, Lars Bo Svendsen, Rikke Løvendahl Eefsen, Michael Wilhelmsen, Ida Katrine Lund, Gunilla Høyer‐Hansen, Hans Jørgen Nielsen, Martin Illemann	16
14	TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases 2015 ·Cancer Research ·Boram Ham, Ni Wang, (unknown), María Celia Fernández, France Bourdeau, Patrick Auguste, Martin Illemann, Rikke Løvendahl Eefsen, Gunilla Høyer‐Hansen, Ben Vainer, Maximilien Evrard, Zu‐Hua Gao, Pnina Brodt	82
15	Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy 2015 ·Cancer Microenvironment ·Rikke Løvendahl Eefsen, Lars H. Engelholm, Warner Alpízar‐Alpízar, (unknown), Peter Vermeulen, Ib Jarle Christensen, Ole Didrik Lærum, (unknown), Gunilla Høyer‐Hansen, Ben Vainer, Kell Østerlind, Martin Illemann	16
16	Tissue inhibitor of matrix metalloproteinase‐1 expression in colorectal cancer liver metastases is associated with vascular structures 2015 ·Molecular Carcinogenesis ·Martin Illemann, Rikke Løvendahl Eefsen, Nigel C. Bird, Ali W. Majeed, Kell Østerlind, Ole Didrik Lærum, Warner Alpízar‐Alpízar, Ida Katrine Lund, Gunilla Høyer‐Hansen	20
17	Growth pattern of colorectal liver metastasis as a marker of recurrence risk 2015 ·Clinical & Experimental Metastasis ·Rikke Løvendahl Eefsen, Peter Vermeulen, Ib Jarle Christensen, Ole Didrik Lærum, (unknown), (unknown), Gert G. Van den Eynden, Gunilla Høyer‐Hansen, Kell Østerlind, Ben Vainer, Martin Illemann	66
18	The morphological growth patterns of colorectal liver metastases are prognostic for overall survival 2014 ·Modern Pathology ·K. Nielsen, (unknown), Rikke Løvendahl Eefsen, Ben Vainer	73
19	The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications 2013 ·Cancer Research ·Gert G. Van den Eynden, Ali W. Majeed, Martin Illemann, Peter Vermeulen, Nigel C. Bird, Gunilla Høyer‐Hansen, Rikke Løvendahl Eefsen, Andrew R. Reynolds, Pnina Brodt	171
20	Comparison of Classical Dermatoscopy and Acrylic Globe Magnifier Dermatoscopy 2008 ·Acta Dermato Venereologica ·Henrik Lorentzen, Rikke Løvendahl Eefsen, K Weismann	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact